Strides Pharma Science Ltd

NSE: STAR · BSE: 532531 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,103.30
Market cap: ₹10,169 Cr
Revenue (annual): ₹4,859 Cr
Net profit (annual): ₹556.2 Cr
P/E (TTM): 16.6×Sector 47.4×
Promoter holding: 27.91%+0.00% QoQ
FII holding: 28.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Sep 2026 21:47 IST BSE

Business Update

Strides Pharma Science Business Update

Strides Pharma Science received a Form 483 with three observations following a routine USFDA inspection at its Alathur formulations facility. The company will respond within stipulated timelines.

Read the filing ↗

19 Aug 2026 19:37 IST BSE

Business Update

Strides Pharma Science Business Update

Strides Pharma Science received a USFDA Establishment Inspection Report (EIR) for its Bengaluru facility. This confirms the successful closure of the recent cGMP inspection.

Read the filing ↗

14 Aug 2026 17:08 IST BSE

Annual General Meeting

Strides Pharma Science Annual General Meeting

Strides Pharma Science Ltd held its 35th Annual General Meeting on August 14, 2026. The meeting transacted ordinary and special business items.

Read the filing ↗